Impressive Credentials

Your recent discussion of me and other unemployed scientists ["Emigre Soviet Scientists Remain Jobless In U.S., Despite Experience," The Scientist, Sept. 17, 1990, page 1] failed to include the fact that I have to my credit 56 scientific papers, books, 13 patents, and a postdoctoral degree (only 10 percent of Soviet scientists get this degree). Nor did the article mention the many USSR aerospace projects in which I took part. Moreover, the article did not make clear that while I was indeed a pr

Written byAlexander Bolonkin
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Your recent discussion of me and other unemployed scientists ["Emigre Soviet Scientists Remain Jobless In U.S., Despite Experience," The Scientist, Sept. 17, 1990, page 1] failed to include the fact that I have to my credit 56 scientific papers, books, 13 patents, and a postdoctoral degree (only 10 percent of Soviet scientists get this degree). Nor did the article mention the many USSR aerospace projects in which I took part.

Moreover, the article did not make clear that while I was indeed a prisoner in the Soviet Union, I was a well-known political prisoner, not a criminal. Andrei Sakharov fought for my release.

I was under the impression that the article was intended to help Soviet scientists get jobs in the United States and make a contribution to science and technology in this fine country. Owing to the above-mentioned omissions from the article, I am afraid I may never get ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies